A family of institutions
working together on the Can Ruti Campus
 

News

Tuberculosis BCG vaccine found ineffective against COVID-19 in healthcare workers

An international trial has investigated the potential immune-boosting effects of the tuberculosis BCG vaccine against COVID-19. The results show that the risk of developing the disease during the first six months after vaccination was not reduced in participants as originally hoped for. Nearly 4,000 healthcare workers took part in the BRACE trial across 36 sites from five countries, including the Germans Trias Hospital. Researchers from an IGTP tuberculosis research group were involved in the development of the study, which has been published in the New England Journal of Medicine.

IGTP introduces super-resolution microscope at CMCiB

A state-of-the-art super-resolution fluorescence confocal microscope, called Abberior Infinity, was installed in the high-level biosafety (NCB3) facility of the Centre for Comparative Medicine and Bioimage (CMCiB). The equipment of this class, unique in the region, is a powerful tool for anyone aiming to perform advanced microscopy studies on fully infectious Level 3 pathogens (HIV, SARS-CoV-2, Monkey Pox, TB etc.) The microscope is available for use by all internal and external users via IGTP Microscopy Platform.

Events

L'IGTP en xifres

  • 795

    Contracted and seconded research staff

  • 289

    Active projects

  • 1022

    Publications

  • 657

    Active clinical trials

  • 40

    Patent families

  • 23

    License agreements

  • 8

    Active spin-Offs

The IGTP is an accredited centre of Excellence of the Instituto de Salud Carlos III (Spanish Government)

Instituto de Salud Carlos III


The IGTP is a member of


Governance


With the support of


Accreditation

  • HR Excellence in Research